Universe Pharmaceuticals INC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Jiangxi Universe Pharmaceuticals obtains a $5 million working capital loan from Jian Rural Communications Bank to support business operations.
NASDAQ
Universe Pharmaceuticals INC obtains a $1.37 million working capital loan from Bank of Beijing Co., Ltd. to support its business operations.